Affordable Access

Sexually Transmitted Disease Testing and Uptake of Human Papillomavirus Vaccine in a Large Online Survey of US Men Who Have Sex With Men at Risk for HIV Infection, 2012.

Authors
  • Kahle, Erin M1
  • Meites, Elissa
  • Sineath, R Craig
  • Nasrullah, Muazzam
  • Bowles, Kristina E
  • DiNenno, Elizabeth
  • Sullivan, Patrick S
  • Sanchez, Travis
  • 1 From the *Department of Health Behavior and Biological Sciences, School of Nursing, University of Michigan, Ann Arbor, MI; †Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA; ‡ Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA; and §Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
Type
Published Article
Journal
Sexually transmitted diseases
Publication Date
Jan 01, 2017
Volume
44
Issue
1
Pages
62–66
Identifiers
PMID: 27898576
Source
Medline
License
Unknown

Abstract

National guidelines recommend annual human immunodeficiency virus (HIV)/sexually transmitted disease testing for sexually active men who have sex with men (MSM) and vaccination against human papillomavirus for MSM through age 26. A 2012 online survey of 2,794 MSM found that 51%, 36%, and 14% reported receiving human immunodeficiency virus testing, sexually transmitted disease testing, and human papillomavirus vaccination, respectively.

Report this publication

Statistics

Seen <100 times